2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1750483327 M.D.
Verify on CMS →

BACHAR KURDI, M.D.

Endocrinology, Diabetes & Metabolism Physician in FOUNTAIN VALLEY, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 117 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
20.3049/100
▼ 63 pts below national avg 83.1 · [object Object]
Industry payments
$363.04
14 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BACHAR KURDI, M.D. reported a CMS MIPS final score of 20.3049/100 — below the 83.1 national average — and filed 1,918 Medicare Part D claims in 2023.

20.3049/100
MIPS score · -63 vs avg
2K
Part D claims, 2023
73%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BACHAR KURDI, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

20 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). This entry sits in this band. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

BACHAR KURDI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BACHAR KURDI, M.D.?

Below national average

NPI registry status

Active

Issued 09/02/2006

NPI 1750483327

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

1,918 27% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

20.3049/100 62.79509999999999% pts

Below average band

vs 83.1 national avg

Specialty distribution in California

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among California providers

California providers

Endocrinology, Diabetes & Metabolism Physician share within California

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within California

Medicare quality performance — MIPS

BACHAR KURDI, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
20.3049/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 20.3049/100 vs national avg 83.1

0%100%National avg83%20.3%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 20.3049/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BACHAR KURDI, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 11100 WARNER AVE, FOUNTAIN VALLEY, CA, 92708, with a listed phone of (714) 546-5967. NPI 1750483327 was issued on 09/02/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KURDI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,918 prescription claims written by this provider, covering 117 Medicare beneficiaries and totaling roughly $550K in drug spend, split 27% brand-name and 73% generic by claim count, with an opioid prescribing rate of 1.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 20.3049/100 for the 2023 performance year (Quality 0, Cost 67.683), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11100 WARNER AVE
FOUNTAIN VALLEY, CA 92708

Provider Details

NPI 1750483327
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Male
NPI Issued 09/02/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

20.3049
Final Score
Avg: 83.1
0
Quality
67.683
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BACHAR KURDI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$363

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to BACHAR KURDI, M.D.. To verify BACHAR KURDI, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

BACHAR KURDI, M.D. — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 1,918 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,918
Total Claims
$550K
Total Drug Cost
117
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,163
Total Day Supply
122,982
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$491K
Generic Drug Cost
$54K
Opioid Claims
22 (1.1% rate)
Antibiotic Claims
42

Patient Demographics

Average Patient Age
75.9 years
Avg HCC Risk Score
2.43
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BACHAR KURDI, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Amlodipine Besylate
94
Metformin Hcl
87
Levothyroxine Sodium
78
Gabapentin
71
Atorvastatin Calcium
67
Tradjenta
Linagliptin
63
Januvia
Sitagliptin Phosphate
55
Losartan Potassium
55
Rosuvastatin Calcium
53
Glimepiride
43

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How BACHAR KURDI, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

BACHAR KURDI, M.D.'s 1,918 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as KURDI.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BACHAR KURDI, M.D.'s specialty?
BACHAR KURDI, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in FOUNTAIN VALLEY, California. Credentials: M.D..
How much does BACHAR KURDI, M.D. prescribe under Medicare Part D?
In 2023, BACHAR KURDI, M.D. wrote 1,918 Medicare Part D claims totaling $550K in drug costs for 117 beneficiaries.
What is BACHAR KURDI, M.D.'s Medicare quality score?
BACHAR KURDI, M.D. has a CMS MIPS Final Score of 20.3049/100 (Quality: 0, Cost: 67.683). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BACHAR KURDI, M.D. located?
BACHAR KURDI, M.D. is located at 11100 WARNER AVE, FOUNTAIN VALLEY, CA, 92708. Phone: (714) 546-5967.
What is BACHAR KURDI, M.D.'s NPI number?
BACHAR KURDI, M.D.'s National Provider Identifier (NPI) is 1750483327, issued on 09/02/2006.
Does BACHAR KURDI, M.D. prescribe more brand-name or generic drugs?
BACHAR KURDI, M.D.'s prescribing is 27% brand-name and 73% generic drugs by claim count, with $491K in brand drug costs.
Does BACHAR KURDI, M.D. prescribe opioids?
Yes, BACHAR KURDI, M.D. had 22 opioid claims in 2023 with an opioid prescribing rate of 1.1%.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does BACHAR KURDI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, BACHAR KURDI, M.D.'s most frequently prescribed drugs include Amlodipine Besylate, Metformin Hcl, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BACHAR KURDI, M.D. accept Medicare?
BACHAR KURDI, M.D. appears in CMS Medicare data with 1,918 Part D claims and 117 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BACHAR KURDI, M.D.'s credentials?
BACHAR KURDI, M.D.'s NPI is 1750483327 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology